Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence to Treatment With Guselkumab in Bio-Naive Patients With Moderate-to-Severe Plaque Psoriasis: A Romanian Non-Interventional Multi-center Observational Study

NCT07582783 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT07582783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07582783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence to Treatment With Guselkumab in Bio-Naive Patients With Moderate-to-Severe Plaque Psoriasis: A Romanian Non-Interventional Multi-center Observational Study
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Recruiting
Start date
May 15, 2026
Completion date
November 10, 2028
Enrollment
200 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis